Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Topia Life Sciences Limited currently has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This matter is assigned to 1 distinct examiner, which concentrates the company's active prosecution efforts with a single individual. This focused workload means that the immediate success of the company's patent strategy in this area depends on the interactions with this specific examiner. Practitioners should focus on building a clear line of communication with this individual to resolve the pending matter efficiently.
The prosecution is situated within 1 distinct art unit, matching the 1 examiner. This indicates a highly focused administrative presence, as the company is not currently navigating multiple specialized groups at the patent office. Legal teams can concentrate their resources on the specific procedural nuances and examination trends of this 1 art unit rather than managing diverse requirements across different groups. This concentration allows for a highly specialized and targeted prosecution approach.
LEVICKY, WILLIAM J is the busiest examiner for this portfolio, holding 1 pending office action. Since this is the only pending action for the company, this examiner is responsible for the entire active workload. This concentration makes the specific examination style and prior art preferences of this individual the primary factor in the company's current patent prosecution experience. The outcome of this 1 pending matter will define the company's immediate success in this technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEVICKY, WILLIAM J | 1 | 69.4% | +29.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19109347 | AN ARTIFICIAL INTELLIGENCE ENABLED WEARABLE ECG SKIN PATCH TO DETECT SUDDEN CARDIAC ARREST | LEVICKY, WILLIAM J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19109347 | AN ARTIFICIAL INTELLIGENCE ENABLED WEARABLE ECG SKIN PATCH TO DETECT SUDDEN CARDIAC ARREST | LEVICKY, WILLIAM J | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19109347 | AN ARTIFICIAL INTELLIGENCE ENABLED WEARABLE ECG SKIN PATCH TO DETECT SUDDEN CARDIAC ARREST | LEVICKY, WILLIAM J | 3796 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 06, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTopia Life Sciences Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
William J Levicky has the most, with 1 of Topia Life Sciences Limited's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.